Third FDA rejection for Verrica’s molluscum contagiosum drug

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 26, 2022 at 11:02: AM
via Shares in US biotech Verrica Pharma lost half their value today after the FDA declined to approve its candidate treatment for viral skin infection molluscum contagiosum for a third time.

article source
 

<



Similar threads

cafead
Alvotech to raise cash after third FDA rejection for Humira biosimilar
Replies
0
Views
301
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Urges Independent Verification of Third-Party Testing Data
Replies
0
Views
111
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Rejects Lilly’s Eczema Treatment Over Third-Party Manufacturing Issues
Replies
0
Views
114
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
Replies
0
Views
128
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
5 FDA decisions to watch in the third quarter
Replies
0
Views
143
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote